105
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Genotypic characterization of Pseudomonas aeruginosa isolates from Turkish children with cystic fibrosis

, , , , , , , & show all
Pages 675-685 | Published online: 27 Mar 2019

References

  • Currie AJ, Speert DP, Davidson DJ. Pseudomonas aeruginosa: role in the pathogenesis of the CF lung lesion. Semin Respir Crit Care Med. 2003;24:671–680. doi:10.1055/s-2004-81566316088583
  • Kosorok MR, Zeng L, West SE, et al. Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Pediatr Pulmonol. 2001;32:277–287.11568988
  • Boukadida J, De Montalembert M, Lenoir G, Scheinmann P, Veron M, Berche P. Molecular epidemiology of chronic pulmonary colonisation by Pseudomonas aeruginosa in cystic fibrosis. J Med Microbiol. 1993;38:29–33. doi:10.1099/00222615-38-1-298418289
  • Hunfeld KP, Schmidt C, Krackhardt B, et al. Risk of Pseudomonas aeruginosa cross-colonisation in patients with cystic fibrosis within a holiday camp-a molecular-epidemiological study. Wien Klin Wochenschr. 2000;112:329–333.10849957
  • Pujana I, Gallego L, Martin G, Lopez F, Canduela J, Cisterna R. Epidemiological analysis of sequential Pseudomonas aeruginosa isolates from chronic bronchiectasis patients without cystic fibrosis. J Clin Microbiol. 1999;37:2071–2073.10325384
  • Silbert S, Barth AL, Sader HS. Heterogeneity of Pseudomonas aeruginosa in Brazilian cystic fibrosis patients. J Clin Microbiol. 2001;39:3976–3981. doi:10.1128/JCM.39.11.3976-3981.200111682517
  • Struelens MJ, Schwam V, Deplano A, Baran D. Genome macrorestriction analysis of diversity and variability of Pseudomonas aeruginosa strains infecting cystic fibrosis patients. J Clin Microbiol. 1993;31:2320–2326.8408549
  • Armstrong DS, Nixon GM, Carzino R, et al. Detection of a widespread clone of Pseudomonas aeruginosa in a pediatric cystic fibrosis clinic. Am J Respir Crit Care Med. 2002;166:983–987. doi:10.1164/rccm.200204-269OC12359658
  • O’Carroll MR, Syrmis MW, Wainwright CE, et al. Clonal strains of Pseudomonas aeruginosa in paediatric and adult cystic fibrosis units. Eur Respir J. 2004;24:101–106.15293611
  • Jones AM, Govan JR, Doherty CJ, et al. Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic. Lancet. 2001;358:557–558.11520529
  • McCallum SJ, Corkill J, Gallagher M, Ledson MJ, Hart CA, Walshaw MJ. Superinfection with a transmissible strain of Pseudomonas aeruginosa in adults with cystic fibrosis chronically colonised by P aeruginosa. Lancet. 2001;358:558–560.11520530
  • Scott FW, Pitt TL. Identification and characterization of transmissible Pseudomonas aeruginosa strains in cystic fibrosis patients in England and Wales. J Med Microbiol. 2004;53:609–615. doi:10.1099/jmm.0.45620-015184530
  • Fluge G, Ojeniyi B, Hoiby N, et al. Typing of Pseudomonas aeruginosa strains in Norwegian cystic fibrosis patients. Clin Microbiol Infect. 2001;7:238–243.11422250
  • Speert D, Campbell ME, Henry DA, et al. Epidemiology of Pseudomonas aeruginosa in cystic fibrosis in British Columbia, Canada. Am J Respir Crit Care Med. 2002;166:988–993.12359659
  • Jelsbak L, Johansen HK, Frost AL, et al. Molecular epidemiology and dynamics of Pseudomonas aeruginosa populations in lungs of cystic fibrosis patients. Infect Immun. 2007;75:2214–2224. doi:10.1128/IAI.01282-0617261614
  • Römling U, Kader A, Sriramulu DD, Simm R, Kronvall G. Worldwide distribution of Pseudomonas aeruginosa clone C strains in the aquatic environment and cystic fibrosis patients. Environ Microbiol. 2005;7:1029–1038. doi:10.1111/j.1462-2920.2005.00780.x15946300
  • Ruiz L, Domínguez MA, Ruiz N, Viñas M. Relationship between clinical and environmental isolates of Pseudomonas aeruginosa in a hospital setting. Arch Med Res. 2004;35:251–257. doi:10.1016/j.arcmed.2004.02.00515163469
  • Johnson JK, Arduino SM, Stine OC, Johnson JA, Harris AD. Multilocus sequence typing compared to pulsed-field gel electrophoresis for molecular typing of Pseudomonas aeruginosa. J Clin Microbiol. 2007;45:3707–3712. doi:10.1128/JCM.00560-0717881548
  • Waters V, Zlosnik JE, Yau YC, Speert DP, Aaron SD, Guttman DS. Comparison of three typing methods for Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Eur J Clin Microbiol Infect Dis. 2012;31(12):3341–3350. doi:10.1007/s10096-012-1701-z22843295
  • Wee BA, Tai AS, Sherrard LJ, et al. Whole genome sequencing reveals the emergence of a Pseudomonas aeruginosa shared strain sub-lineage among patients treated within a single cystic fibrosis centre. BMC Genomics. 2018;30(19):644. doi:10.1186/s12864-018-5018-x
  • Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing Sixteenth Informational Supplement M100-BS16. Wayne (PA): CLSI; 2006.
  • Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol. 1995;33:2233–2239.7494007
  • Saiman L, Siegel J, Cystic Fibrosis Foundation. Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission. Infect Control Hosp Epidemiol. 2003;24(5):6–52. doi:10.1086/503485
  • Vosahlikova S, Drevinek P, Cinek O, et al. High genotypic diversity of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis in the Czech Republic. Res Microbiol. 2007;158:324–329. doi:10.1016/j.resmic.2007.02.00317448645
  • Cigana C, Melotti P, Baldan R, et al. Genotypic and phenotypic relatedness of Pseudomonas aeruginosa isolates among the major cystic fibrosis patient cohort in Italy. BMC Microbiol. 2016;16:142. doi:10.1186/s12866-016-0760-127400750
  • Cramer N, Wiehlmann L, Ciofu O, Tamm S, Hoiby N, Tummler B. Molecular epidemiology of chronic Pseudomonas aeruginosa airway infections in cystic fibrosis. PLoS One. 2012;7:e50731. doi:10.1371/journal.pone.005073123209821
  • Saiman L, Siegel JD, LiPuma JJ, et al; Cystic Fibrous Foundation; Society for Healthcare Epidemiology of America. Infection prevention and control guideline for cystic fibrosis: 2013 update. Infect Control Hosp Epidemiol. 2014;35(1):1–67. doi:10.1086/67438924334790
  • Bragonzi A, Paroni M, Nonis A, et al. Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence. Am J Respir Crit Care Med. 2009;180:138–145. doi:10.1164/rccm.200812-1943OC19423715
  • Van Daele SG, Franckx H, Verhelst R, et al. Epidemiology of Pseudomonas aeruginosa in a cystic fibrosis rehabilitation centre. Eur Respir J. 2005;25:474–481. doi:10.1183/09031936.05.0005030415738291
  • Leone I, Chirillo MG, Raso T, Zucca M, Savoia D. Phenotypic and genotypic characterization of Pseudomonas aeruginosa from cystic fibrosis patients. Eur J Clin Microbiol Infect Dis. 2008;27:1093–1099. doi:10.1007/s10096-008-0551-118488256
  • Logan C, Habington A, Lennon G, et al. Genetic relatedness of Pseudomonas aeruginosa isolates among a paediatric cystic fibrosis patient cohort in Ireland. J Med Microbiol. 2012;61:64–70. doi:10.1099/jmm.0.035642-021921114
  • Mowat E, Paterson S, Fothergill JL, et al. Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections. Am J Respir Crit Care Med. 2011;183:1674–1679. doi:10.1164/rccm.201009-1430OC21297072
  • Workentine ML, Sibley CD, Glezerson B, et al. Phenotypic heterogeneity of Pseudomonas aeruginosa populations in a cystic fibrosis patient. PLoS One. 2013;8:e60225. doi:10.1371/journal.pone.006022523573242
  • Finnan S, Morrissey JP, O’Gara F, Boyd EF. Genome diversity of Pseudomonas aeruginosa isolates from cystic fibrosis patients and the hospital environment. J Clin Microbiol. 2004;42:5783–5792. doi:10.1128/JCM.42.12.5783-5792.200415583313